Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PKC inhibitors(Protein kinase C inhibitors), PLC inhibitors(Phospholipase C inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC11H16OS2 |
InChIKeyPWLXJBSAUKKGCM-IGORNWKESA-N |
CAS Registry1096688-09-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Herpes Simplex | Phase 1 | - | - | |
Herpes Simplex | Phase 1 | CH | - | |
Human Papillomavirus Infection | Phase 1 | DE | - | |
Human Papillomavirus Infection | Phase 1 | - | - |